Pilar Mozas Alonso

Title: Pilar Mozas Alonso: Innovator in Genetic Mutation Detection

Introduction

Pilar Mozas Alonso is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of genetics, particularly in the detection of mutations associated with familial hypercholesterolemia. Her innovative work has the potential to impact the diagnosis and treatment of this genetic condition.

Latest Patents

Pilar holds a patent for a "Method and device for the detection of mutations in isolated gene sequences of the low-density lipoprotein receptor (LDL-r) which is associated with familial hypercholesterolemia." This invention relates to extracorporeal methods of analyzing the presence or absence of mutations that cause familial hypercholesterolemia. The methods she developed utilize a DNA sample from an individual and include a polymerase chain reaction with primers complementary to the LDL receptor gene. The analysis of the amplified product is conducted through sequencing, restriction analysis, single strand conformation polymorphism techniques, heteroduplex analysis, and a device on a biochip glass support with oligonucleotide probes to detect the mutations in the DNA. Pilar has 1 patent to her name.

Career Highlights

Pilar is currently associated with Progenika Biopharma S.A., where she continues to advance her research in genetic testing and diagnostics. Her work is crucial in the ongoing efforts to improve healthcare outcomes for individuals with genetic predispositions to certain conditions.

Collaborations

Pilar collaborates with notable colleagues, including Gilberto Reyes Leal and Antonio Martinez Martinez. These partnerships enhance her research capabilities and contribute to the development of innovative solutions in the field of genetics.

Conclusion

Pilar Mozas Alonso is a trailblazer in the realm of genetic mutation detection, with her patented methods paving the way for advancements in medical diagnostics. Her contributions are vital for understanding and addressing familial hypercholesterolemia, showcasing the importance of innovation in healthcare.